Variable† | Anti-TNF* Group | MTX Group | Rituximab Group | ||||||
---|---|---|---|---|---|---|---|---|---|
T0 | T12 | p | T0 | T12 | p | T0 | T12 | p | |
QT | 400.88 ± 25.74 | 414.41 ± 27.10 | 0.009 | 390.8 ± 29.2 | 401.1 ± 28.4 | NS | 416.2 ± 27.1 | 416.2 ± 31.9 | NS |
QTc | 443.56 ± 25.55 | 450.85 ± 27.24 | NS | 435.4 ± 26.0 | 439.4 ± 20.3 | NS | 457.4 ± 19.9 | 447.6 ± 23.6 | NS |
QTd | 27.94 ± 8.8 | 42.94 ± 10.01 | < 0.0001 | 29.2 ± 9.7 | 32.3 ± 11.1 | NS | 31.2 ± 8.8 | 27.5 ± 9.6 | NS |
QTdc | 31.38 ± 11.33 | 46.71 ± 11.0 | < 0.0001 | 32.4 ± 10.9 | 35.1 ± 11.2 | NS | 34.2 ± 9.2 | 29.4 ± 10.0 | NS |